Date published: 2025-9-11

1-800-457-3801

SCBT Portrait Logo
Seach Input

ERGIC-53L Activators

ERGIC-53L Activators encompass a spectrum of chemical compounds that indirectly promote the functional activity of ERGIC-53L through a variety of intracellular mechanisms impacting glycoprotein processing and trafficking. Calcium ionophore A23187 and Thapsigargin, by increasing intracellular calcium levels, directly enhance the lectin activity of ERGIC-53L, pivotal for binding glycoproteins in the ER-Golgi intermediate compartment. Similarly, Brefeldin A disrupts Golgi structure, which could lead to an upsurge in the functional demand for ERGIC-53L in glycoprotein sorting. Ionophores such as Nigericin and Monensin alter ion gradients, indirectly necessitating greater ERGIC-53L activity to maintain glycoprotein processing within the altered ionic milieu of the Golgi. Meanwhile, inhibitors of glycoprotein processing enzymes, like Swainsonine, Castanospermine, Deoxynojirimycin,and Kifunensine, cause an accumulation of glycoproteins in the ER, thereby potentially augmenting the need for ERGIC-53L's role in their proper trafficking. This is essential since ERGIC-53L is crucial in the quality control and movement of glycoproteins from the ER to the Golgi apparatus.

Moreover, compounds such as Bafilomycin A1, FCCP, and Nocodazole disrupt various aspects of intracellular trafficking and organelle function, which may indirectly enhance the importance of ERGIC-53L in the cellular logistics of glycoprotein handling. Bafilomycin A1, by inhibiting V-ATPase, affects endosomal acidification and could thereby increase reliance on ERGIC-53L for bypassing compromised trafficking routes. FCCP's action in dissipating proton gradients can impact organelle function, possibly leading to increased ERGIC-53L activity to counterbalance disrupted glycoprotein transport. Lastly, Nocodazole's disruption of microtubules may lead to a greater dependence on ERGIC-53L function for the intracellular transport of glycoproteins, highlighting the adaptability of ERGIC-53L in response to cellular stressors that impinge on its primary function in glycoprotein trafficking.

SEE ALSO...

Items 41 to 11 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING